Cavolo Nero (Brassica oleracea var. palmifolia)

Cavolo nero (Brassica oleracea var. palmifolia) is a dark leafy crucifer rich in glucosinolates, kaempferol, and quercetin that exert anti-inflammatory and neuroprotective effects. Its bioactive compounds inhibit acetylcholinesterase activity and suppress pro-inflammatory cytokines including IL-1β and TNF-α through modulation of inflammatory signaling cascades.

Origin & History

Cavolo Nero (Brassica oleracea var. palmifolia), also known as Tuscan black kale or Nero di Toscana, is a dark leafy green vegetable originating from Tuscany, Italy, belonging to the Brassicaceae family. It is consumed as a whole plant, with seeds and leaves serving as sources for bioactive compounds like glucoraphanin, which can be isolated via grinding, defatting with hexane, and enzymatic hydrolysis to yield sulforaphane. This cruciferous vegetable is rich in glucosinolates and phenolics, categorized by USDA as a nutrient-dense food due to high levels of antioxidants and vitamins.

Historical & Cultural Context

No specific historical or traditional medicinal uses of Cavolo Nero were identified in documented systems like Ayurveda or TCM. It is primarily noted as a culinary vegetable from Tuscany, Italy, with modern research highlighting its potential as a functional food source post-fermentation.

Health Benefits

• Anti-inflammatory effects: Fermented extracts showed 15-fold decrease in IL-1β and 10-fold decrease in TNF-α at 250 µg/mL (in vitro evidence only)
• Neuroprotective potential: Exhibits acetylcholinesterase inhibition up to 44.5% and enhanced butyrylcholinesterase inhibition post-fermentation (preliminary in vitro data)
• Antioxidant activity: Increases SOD up to 47%, preserves CAT and GSH levels, and reduces oxidative stress markers in cell studies (in vitro evidence)
• Cellular protection: Demonstrated cytoprotective effects in Caco-2 cells with reduced MDA and LDH at 250 µg/mL (preliminary laboratory evidence)
• Potential chemoprevention: R-sulforaphane from seeds induces Keap1/Nrf2/ARE pathway and phase II detoxification enzymes (mechanism studies only)

How It Works

Cavolo nero's glucosinolate-derived isothiocyanates, including sulforaphane analogs, activate the Nrf2/Keap1 pathway to upregulate antioxidant response elements and suppress NF-κB-mediated transcription of pro-inflammatory cytokines IL-1β and TNF-α. Fermented cavolo nero extracts demonstrate enhanced cholinesterase inhibition, with acetylcholinesterase activity reduced by up to 44.5% and butyrylcholinesterase inhibition further potentiated post-fermentation, suggesting biotransformation increases bioavailability of active phenolic and glucosinolate metabolites. Flavonoids kaempferol and quercetin contribute to anti-inflammatory effects by inhibiting COX-2 enzyme activity and modulating MAPK signaling pathways.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Cavolo Nero were identified. Current evidence is limited to in vitro studies using fermented leaf extracts in Caco-2 cells, showing anti-cholinesterase, cytoprotective, and anti-inflammatory activities at concentrations up to 250 µg/mL. Related sulforaphane compounds have been noted in animal models, but no human trial PMIDs for Cavolo Nero itself are available.

Clinical Summary

Available evidence for cavolo nero is predominantly in vitro, with fermented extracts tested at 250 µg/mL demonstrating a 15-fold reduction in IL-1β and a 10-fold reduction in TNF-α in cell-based inflammatory models. Acetylcholinesterase inhibition reaching 44.5% has been documented in enzyme assay studies, with butyrylcholinesterase inhibition amplified following lactic acid fermentation, suggesting fermentation as a processing variable of pharmacological relevance. No human clinical trials or animal intervention studies specific to cavolo nero extract have been identified in the published literature, making all mechanistic findings preliminary and not directly translatable to human dosing recommendations. The evidence base is insufficient to establish efficacious doses, and extrapolation from related Brassica oleracea research should be done cautiously.

Nutritional Profile

Cavolo Nero (Tuscan/Lacinato kale) per 100g raw: Macronutrients — Calories ~35 kcal, Carbohydrates ~5.4g (of which sugars ~1.6g), Dietary Fiber ~2.0–3.6g (predominantly insoluble cellulose and hemicellulose), Protein ~3.3g (containing all essential amino acids; notably high in leucine and lysine relative to other leafy vegetables), Fat ~0.7g (including alpha-linolenic acid ~0.1g). Micronutrients — Vitamin K1 (phylloquinone): 704–817 µg (bioavailability moderate; fat-soluble, absorption enhanced with dietary lipids); Vitamin C (ascorbic acid): 93–120 mg (highly bioavailable but heat-labile, significant losses with boiling); Vitamin A (as beta-carotene): ~9990 IU (~681 µg RAE; absorption ~3–6x lower than preformed vitamin A, enhanced by cooking and fat co-ingestion); Vitamin B6: ~0.27 mg; Folate: ~141 µg DFE; Calcium: ~135–150 mg (bioavailability ~40–49%, notably higher than cow's milk on a per-calorie basis; oxalate content lower than spinach, estimated 100–200 mg oxalate/100g); Iron: ~1.5 mg (non-heme; bioavailability 5–12%, enhanced by co-consumed vitamin C); Magnesium: ~34 mg; Potassium: ~447 mg; Manganese: ~0.66 mg; Phosphorus: ~55 mg; Copper: ~0.29 mg; Zinc: ~0.44 mg (moderate phytate interference). Bioactive Compounds — Glucosinolates: Total ~50–100 mg/100g fresh weight, primarily glucoraphanin (~20–40 mg/100g), sinigrin, and glucobrassicin; enzymatic hydrolysis via myrosinase (activated by chewing or chopping) yields sulforaphane (isothiocyanate) and indole-3-carbinol, which drive Phase II enzyme induction (Nrf2 pathway activation); cooking inactivates myrosinase but gut microbiota can partially compensate. Carotenoids: Lutein + zeaxanthin ~18.2 mg/100g (among highest of leafy vegetables; fat-soluble, bioavailability significantly improved with oil). Flavonoids: Quercetin ~22–34 mg/100g, kaempferol ~17–21 mg/100g, isorhamnetin present in smaller quantities; glycosylated forms are less bioavailable than aglycones, partially deglycosylated by gut microbiota. Chlorophyll: ~100–300 mg/100g (chlorophyll a and b); acts as antioxidant and may inhibit mutagen absorption. Polyphenols: Total ~200–400 mg GAE/100g (including hydroxycinnamic acids: sinapic acid, caffeic acid derivatives). Anthocyanins: Present in darkened or cold-stressed leaves at low concentrations (<5 mg/100g). Bioavailability Notes: Steaming preserves glucosinolate precursors and vitamin C better than boiling (which leaches 40–60% water-soluble nutrients); consuming with healthy fats substantially increases carotenoid and vitamin K absorption; fermentation (lacto-fermentation) has been shown to increase polyphenol bioavailability, reduce anti-nutritional factors, and generate bioactive peptides — consistent with the enhanced anti-inflammatory and enzymatic inhibition effects noted in fermented extract studies.

Preparation & Dosage

No clinically studied dosages for Cavolo Nero in humans have been established due to lack of human trials. In vitro studies used fermented leaf extracts at concentrations up to 250 µg/mL. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Sulforaphane, Broccoli Sprout Extract, Vitamin C, Quercetin, Turmeric

Safety & Interactions

Cavolo nero contains goitrogens, specifically glucosinolates that hydrolyze to goitrins, which can interfere with thyroid iodine uptake and may worsen hypothyroidism, particularly when consumed raw in large quantities. Individuals taking warfarin or other vitamin K-dependent anticoagulants should monitor intake carefully, as cavolo nero's high vitamin K content can reduce anticoagulant efficacy and alter INR values. Those taking thyroid hormone replacement therapy such as levothyroxine should consult a healthcare provider before using concentrated cavolo nero supplements, as timing and quantity relative to medication dosing may affect absorption. Cavolo nero is generally considered safe as a food for pregnant and breastfeeding women in culinary amounts, but concentrated extracts or fermented supplement forms lack safety data for these populations.